Publications by authors named "Ian Ragan"

Claim this Profile
N
New supporting data to guide the use of evident toxicity in acute oral toxicity studies (OECD TG 420).
Fiona Sewell, Ian Ragan, Graham Horgan, David Andrew, Thomas Holmes

Regul Toxicol Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP).
Sarah J Bailey, Tobias Bast, Lauren Chaby, Bruce J Kinon, Michael K Harte, Ian Ragan

J Psychopharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refinements to rodent head fixation and fluid/food control for neuroscience.
Chris Barkus, Caroline Bergmann, Tiago Branco, Matteo Carandini, Paul T Chadderton, C Ian Ragan

J Neurosci Methods· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Current Status and Work of Three Rs Centres and Platforms in Europe.
Winfried Neuhaus, Birgit Reininger-Gutmann, Beate Rinner, Roberto Plasenzotti, Doris Wilflingseder, Ian Ragan

Altern Lab Anim· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprint of: Production of Superoxide Radicals and Hydrogen Peroxide by NADH- Ubiquinone Reductase and Ubiquinol-Cytochrome c Reductase from Beef-Heart Mitochondria.
Enrique Cadenas, Alberto Boveris, C Ian Ragan, Andres O M Stoppani

Arch Biochem Biophys· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rise of Three Rs Centres and Platforms in Europe.
Winfried Neuhaus, Birgit Reininger-Gutmann, Beate Rinner, Roberto Plasenzotti, Doris Wilflingseder, Ian Ragan

Altern Lab Anim· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals.
Elliot Lilley, Richard Isbrucker, Ian Ragan, Anthony Holmes

Biologicals· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical screening for antidepressant activity - shifting focus away from the Forced Swim Test to the use of translational biomarkers.
Fiona Sewell, Ian Waterson, David Jones, Mark David Tricklebank, Ian Ragan

Regul Toxicol Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of the fixed concentration procedure for assessment of acute inhalation toxicity.
Fiona Sewell, Ian Ragan, Ian Indans, Tim Marczylo, Nigel Stallard

Regul Toxicol Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying the 3Rs to non-human primate research: Barriers and solutions.
Mark J Prescott, Jan A Langermans, Ian Ragan

Drug Discov Today Dis Models· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments).
Nathalie Percie du Sert, Alessio Alfieri, Stuart M Allan, Hilary Vo Carswell, Graeme A Deuchar, C Ian Ragan

J Cereb Blood Flow Metab· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steps towards the international regulatory acceptance of non-animal methodology in safety assessment.
Fiona Sewell, John Doe, Nichola Gellatly, Ian Ragan, Natalie Burden

Regul Toxicol Pharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drivers and barriers in the consistency approach for vaccine batch release testing: Report of an international workshop.
Martijn W P Bruysters, Marie-Jeanne Schiffelers, Marieke Hoonakker, Carmen Jungbaeck, Ian Ragan

Biologicals· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
Sylvie Morgeaux, Bertrand Poirier, C Ian Ragan, Dianna Wilkinson, Ulrich Arabin

Vaccine· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges.
Kathryn Chapman, Akosua Adjei, Paul Baldrick, Antonio da Silva, Karen De Smet, Ian Ragan

MAbs· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities for improving animal welfare in rodent models of epilepsy and seizures.
Katie Lidster, John G Jefferys, Ingmar Blümcke, Vincenzo Crunelli, Paul Flecknell, Ian Ragan

J Neurosci Methods· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A global initiative to refine acute inhalation studies through the use of 'evident toxicity' as an endpoint: Towards adoption of the fixed concentration procedure.
Fiona Sewell, Ian Ragan, Tim Marczylo, Brian Anderson, Anne Braun

Regul Toxicol Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials.
Fiona Sewell, Kathryn Chapman, Paul Baldrick, David Brewster, Alan Broadmeadow, Ian Ragan

Regul Toxicol Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lab animals: Can GM marmoset use be justified?
Patrick Bateson, C Ian Ragan

Nature· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European Union.
Erwin Annys, Richard Billington, Rick Clayton, Klaus-Dieter Bremm, Michael Graziano, Ian Ragan

Regul Toxicol Pharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What should we do about student use of cognitive enhancers? An analysis of current evidence.
C Ian Ragan, Imre Bard, Ilina Singh,

Neuropharmacology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primates.
Kathryn L Chapman, Laura Andrews, Jeffrey J Bajramovic, Paul Baldrick, Lauren E Black, C Ian Ragan

Regul Toxicol Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus document on European brain research.
Monica Di Luca, Mary Baker, Renato Corradetti, Helmut Kettenmann, Julien Mendlewicz, Ian Ragan

Eur J Neurosci· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of monoclonal antibodies: considerations for the use of non-human primates.
Kathryn Chapman, Nick Pullen, Lee Coney, Maggie Dempster, Laura Andrews, Ian Ragan

MAbs· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of non-human primate use in mAb development.
Kathryn L Chapman, Nick Pullen, Laura Andrews, Ian Ragan

Drug Discov Today· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis